Try our Advanced Search for more refined results

Chancery OKs Anixa Reform Deal To End Repriced-Stock Suit

By Rose Krebs (October 1, 2019, 8:44 PM EDT) -- A Delaware vice chancellor approved a deal on Tuesday that ends an Anixa Biosciences Inc. investor's derivative suit, which will institute governance changes to address claims company directors downpriced stock options held by insiders in 2017 while delaying a patent award announcement that bumped up option values....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!